# Dextenza Within Upper Lid Canaliculus Compared With Lower Lid Canaliculus Following Bilateral Cataract Extraction Surgery With PCIOL.

> **NCT04592081** · PHASE4 · UNKNOWN · sponsor: **Kerry Assil, MD** · enrollment: 20 (estimated)

## Conditions studied

- Post-Surgical Ocular Pain
- Post-Surgical Ocular Inflammation

## Interventions

- **DRUG:** Dextenza 0.4Mg Ophthalmic Insert

## Key facts

- **NCT ID:** NCT04592081
- **Lead sponsor:** Kerry Assil, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-03-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04592081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04592081, "Dextenza Within Upper Lid Canaliculus Compared With Lower Lid Canaliculus Following Bilateral Cataract Extraction Surgery With PCIOL.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04592081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*